Checked
Federal dataHealth
Ceritinib
Published by U.S. Food and Drug Administration · Updated 03/17/2025 · Yearly
- Last updated
- 03/17/2025
- First published 09/16/2016
- Update frequency
- Yearly
- Formats
- Web only
- Coverage
- Nationwide
- Federal data
About this dataset
Zykadia (ceritinib) is a prescription oral tablet made by Novartis Pharmaceuticals Corporation. It is a kinase inhibitor used to treat certain types of lung cancer, such as ALK-positive metastatic non-small cell lung cancer. Each tablet contains 150 mg of ceritinib. This information was generated using AI and is provided for informational and research purposes only.
Files and access
Links open the official government source
- Ceritinibaccessdata.fda.govWeb page
Links open outside websites we do not control.
Frequently asked questions
- Who publishes Ceritinib?
- U.S. Food and Drug Administration, part of U.S. Department of Health & Human Services, publishes this dataset on Data.gov.
- How often is it updated?
- The publisher lists the update frequency as yearly. The last update was on 03/17/2025.
- How do I download it?
- Use the official source link above to view or request the data.
Similar data from other publishers
- CeritinibState of VirginiaZykadia (ceritinib) is a prescription oral tablet made by Novartis Pharmaceuticals Corporation. It is a kinase inhibitor used to treat certain types of lung cancer, such as ALK-positive metastatic non-small cell lung cancer. Each tablet contains 150 mg of ceriUpdated 09/29/2026
- CeritinibState of VirginiaZykadia (ceritinib) is a prescription oral tablet made by Novartis Pharmaceuticals Corporation. It is a kinase inhibitor used to treat certain types of lung cancer, such as ALK-positive metastatic non-small cell lung cancer. Each tablet contains 150 mg of ceriUpdated 03/24/2026
- AvapritinibState of VirginiaAyvakit (avapritinib) is a prescription oral tablet medication manufactured by Blueprint Medicines Corporation. It acts as a kinase inhibitor, specifically targeting tyrosine kinases, and is used to treat certain cancers like gastrointestinal stromal tumors anUpdated 07/06/2026
- AvapritinibState of VirginiaAyvakit (avapritinib) is a prescription oral tablet medication manufactured by Blueprint Medicines Corporation. It acts as a kinase inhibitor, specifically targeting tyrosine kinases, and is used to treat certain cancers like gastrointestinal stromal tumors anUpdated 09/29/2026
- CapmatinibState of VirginiaTABRECTA (capmatinib) is an oral prescription medication from Novartis Pharmaceuticals Corporation, approved to treat adults with metastatic non-small cell lung cancer (NSCLC) that has a specific genetic mutation (MET exon 14 skipping). It comes as film-coatedUpdated 05/26/2026
Where this catalog comes from
- Data.gov CatalogU.S. General Services Administration
- State and local open data portalsSocrata Discovery API
- State and city CKAN portalsCalifornia, Virginia, Boston, Houston and more
- Government ArcGIS Hub sitesCity and county GIS data
Catalog checked 10/24/2026
We list dataset descriptions only. Downloads and APIs link straight to the official government source, which holds the current version and its terms of use.
Source: Data.gov · Last updated 10/24/2026 · Listing only; the data stays with the publisher
Share: